COMPANY PROFILE // THE 014 REPORT
OmniAb, Inc.
OABI (Nasdaq) · OABIW (Nasdaq) · Formerly: Avista Public Acquisition Corp. II
Assembled from 2 government sources in 2.4 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
No flag from the records checked. 24 of 26 lists and sources checked came back clear (panel below).
✓ SEC filings✗ LEI✗ SAM registration✗ IRS return✗ State registration✗ Website✗ Lobbying registration
No LEI, no SAM registration, no IRS return, no state registration, no website, no lobbying registration on record.
OmniAb, Inc. is an SEC-registered operating company in services-commercial physical & biological research, incorporated in DE, based in Emeryville, CA; listed as OABI (Nasdaq), OABIW (Nasdaq).[source] It reported revenue of $18.7 million for the fiscal year ended 2025-12-31.[source] It has filed 49 documents with the SEC in the last 12 months; the latest is Form 4, filed 2026-11-02.[source] Its largest institutional holders on 13F filings are Whitefort Capital Management, LP, BlackRock, Inc., NOMURA HOLDINGS INC (as of 2026-06-30).[source] 24 of 26 lists and sources checked came back clear; the rest are listed with their result.[source]
- red0
- amber0
- info0
- Whitefort Capital Management, LP$25.2M
- BlackRock, Inc.$21.9M
- NOMURA HOLDINGS INC$12.4M
- CADIAN CAPITAL MANAGEMENT, LP$10.4M
- VANGUARD CAPITAL MANAGEMENT LLC$9.5M
- GEODE CAPITAL MANAGEMENT, LLC$7.1M
- RICE HALL JAMES & ASSOCIATES, LLC$6.4M
- PRIVATE MANAGEMENT GROUP INC$5.8M
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Officers and directors (Forms 3, 4, 5)
- Berkman Charles S · Chief Legal Officer (Officer) · latest Form 4 2026-02-18 · filing · LinkedIn search
- FOEHR MATTHEW W · President and CEO (Director,Officer) · latest Form 4 2026-02-18 · filing · LinkedIn search
- GUSTAFSON KURT A · Executive VP, Finance and CFO (Officer) · latest Form 4 2026-02-18 · filing · LinkedIn search
- Bertozzi Carolyn R · Director · latest Form 4 2025-11-03 · filing · LinkedIn search
- Cochran Jennifer R. · Director · latest Form 4 2025-06-18 · filing · LinkedIn search
- Crouse Steven C. · Director · latest Form 4 2025-06-18 · filing · LinkedIn search
- Gotwals Philip J · Director · latest Form 4 2025-06-18 · filing · LinkedIn search
- HIGGINS JOHN L · Director · latest Form 4 2026-01-30 · filing · LinkedIn search
- Love Steven · Director · latest Form 4 2025-11-03 · filing · LinkedIn search
As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 24 CLEAR, 2 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0001846253 | source |
| EIN | 00-0000000 | source |
| Business address (SEC) | 5980 HORTON STREET, EMERYVILLE, CA, 94608 | source |
Does not exist in the records we hold: LEI, UEI, NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2027-03-31 · in 131 days · Next 10-K due (period ended 2026-12-31; Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company) (computed from the fiscal year end and filer status)
- 2027-05-15 · in 176 days · Next 10-Q due (period ended 2027-03-31; Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 8731 (services-commercial physical & biological research): 18 companies in our records share this code.
federal dollars
SEC filings in 12 months
flags
Peers, each with its 014
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 105 SEC filings in 12 months · 1 flag · $263.1M federal (possible match)
- MAXCYTE, INC. · 42 SEC filings in 12 months · 2 flags · $537K federal (possible match)
- INCYTE CORP · 169 SEC filings in 12 months · 3 flags · $160K federal (possible match)
- Medpace Holdings, Inc. · 107 SEC filings in 12 months · 1 flag
- ICON PLC · 91 SEC filings in 12 months · 1 flag
- IQVIA HOLDINGS INC. · 88 SEC filings in 12 months
- bioAffinity Technologies, Inc. · 83 SEC filings in 12 months · 1 flag
- iSpecimen Inc. · 67 SEC filings in 12 months · 3 flags
- Absci Corp · 66 SEC filings in 12 months
- OneMedNet Corp · 65 SEC filings in 12 months · 2 flags
- OmniAb, Inc. · 49 SEC filings in 12 months
- NRC HEALTH · 42 SEC filings in 12 months · 1 flag
SHARED PEOPLE · SHARED ADDRESS
Network neighbours
Shared directors and officers
- Viking Therapeutics, Inc. · FOEHR MATTHEW W
- Xencor Inc · GUSTAFSON KURT A
- ELI LILLY & Co · Bertozzi Carolyn R
- ALNYLAM PHARMACEUTICALS, INC. · Bertozzi Carolyn R
- BIO-TECHNE Corp · Crouse Steven C.
- CAPRICOR THERAPEUTICS, INC. · Gotwals Philip J
- BIO-TECHNE Corp · HIGGINS JOHN L
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-10-30 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-10-30 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-08-06 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-08-06 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-07-13 officer change 8-K items 5.02 · SEC EDGAR
- 2026-06-18 filing 8-K items 5.07 · SEC EDGAR
- 2026-05-07 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-05-07 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-04-29 filing ARS · SEC EDGAR
- 2026-04-29 filing DEFA14A · SEC EDGAR
- 2026-04-29 filing Proxy statement · SEC EDGAR
- 2026-04-07 filing 144 · SEC EDGAR
- 2026-04-07 filing 144 · SEC EDGAR
- 2026-04-07 filing 144 · SEC EDGAR
- 2026-03-04 filing Annual report (10-K) · SEC EDGAR
- 2026-03-04 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-02-17 filing 144 · SEC EDGAR
- 2026-02-17 filing 144 · SEC EDGAR
- 2026-02-17 filing 144 · SEC EDGAR
- 2026-01-30 filing 8-K items 5.03,9.01 · SEC EDGAR
- 2025-12-08 filing 144 · SEC EDGAR
- 2025-12-08 filing 144 · SEC EDGAR
- 2025-12-08 filing 144 · SEC EDGAR
- 2025-11-04 filing Quarterly report (10-Q) · SEC EDGAR
- 2025-11-04 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2025-09-19 filing EFFECT · SEC EDGAR
- 2025-09-17 filing CORRESP · SEC EDGAR
- 2025-09-16 filing UPLOAD · SEC EDGAR
- 2025-09-12 filing S-3 · SEC EDGAR
- 2025-09-10 filing D · SEC EDGAR
167 earlier entries
- 2025-08-25 filing 8-K items 1.01,3.02,7.01,9.01
- 2025-08-06 filing Quarterly report (10-Q)
- 2025-08-06 filing 8-K items 2.02,9.01
- 2025-06-18 filing 8-K items 5.07
- 2025-06-18 insider First Form 3/4/5 on record for Bertozzi Carolyn R (Director)
- 2025-05-15 insider First Form 3/4/5 on record for Cochran Jennifer R. (Director)
- 2025-05-14 insider First Form 3/4/5 on record for Love Steven (Director)
- 2025-05-13 insider First Form 3/4/5 on record for HIGGINS JOHN L (Director)
- 2025-05-08 filing Quarterly report (10-Q)
- 2025-05-08 filing 8-K items 2.02,9.01
- 2025-04-29 filing ARS
- 2025-04-29 filing DEFA14A
- 2025-04-29 filing Proxy statement
- 2025-04-21 officer change 8-K items 5.02
- 2025-04-21 insider First Form 3/4/5 on record for Crouse Steven C. (Director)
- 2025-04-21 insider First Form 3/4/5 on record for Gotwals Philip J (Director)
- 2025-04-07 filing 144
- 2025-04-07 filing 144
- 2025-04-07 filing 144
- 2025-04-07 insider First Form 3/4/5 on record for Berkman Charles S (Chief Legal Officer)
- 2025-04-07 insider First Form 3/4/5 on record for FOEHR MATTHEW W (President and CEO)
- 2025-04-01 filing 144
- 2025-04-01 insider First Form 3/4/5 on record for GUSTAFSON KURT A (Executive VP, Finance and CFO)
- 2025-03-18 filing S-8
- 2025-03-18 filing Annual report (10-K)
- 2025-03-18 filing 8-K items 2.02,9.01
- 2025-02-18 filing 144
- 2025-02-18 filing 144
- 2025-02-18 filing 144
- 2025-01-21 filing 144
- 2025-01-21 filing 144
- 2025-01-21 filing 144
- 2024-12-09 filing 144
- 2024-12-09 filing 144
- 2024-12-09 filing 144
- 2024-11-12 filing Quarterly report (10-Q)
- 2024-11-12 filing 8-K items 2.02,9.01
- 2024-09-27 filing UPLOAD
- 2024-09-24 filing CORRESP
- 2024-09-11 filing UPLOAD
- 2024-08-08 filing Quarterly report (10-Q)
- 2024-08-08 filing 8-K items 2.02,9.01
- 2024-07-02 filing SC 13D/A
- 2024-07-01 officer change 8-K items 5.02
- 2024-06-21 filing 8-K items 5.07
- 2024-05-09 filing Quarterly report (10-Q)
- 2024-05-09 filing 8-K items 2.02,9.01
- 2024-04-26 filing ARS
- 2024-04-26 filing DEFA14A
- 2024-04-26 filing Proxy statement
- 2024-04-08 filing 144
- 2024-04-08 filing 144
- 2024-04-01 filing 144
- 2024-03-25 filing Annual report (10-K)
- 2024-03-20 filing 8-K items 2.02,9.01
- 2023-12-18 filing EFFECT
- 2023-12-18 filing EFFECT
- 2023-12-14 filing CORRESP
- 2023-12-13 filing UPLOAD
- 2023-12-08 filing POS AM
- 2023-12-08 filing S-3
- 2023-11-13 filing 424B3
- 2023-11-09 filing Quarterly report (10-Q)
- 2023-11-09 filing 8-K items 2.02,9.01
- 2023-11-02 filing 424B3
- 2023-11-01 officer change 8-K items 5.02
- 2023-08-10 filing 424B3
- 2023-08-10 filing Quarterly report (10-Q)
- 2023-08-10 filing 8-K items 2.02,9.01
- 2023-06-26 filing 8-K items 5.07
- 2023-05-18 filing 144
- 2023-05-11 filing Quarterly report (10-Q)
- 2023-05-11 filing 8-K items 2.02,9.01
- 2023-05-10 filing EFFECT
- 2023-05-05 filing POS AM
- 2023-05-01 filing ARS
- 2023-05-01 filing DEFA14A
- 2023-05-01 filing Proxy statement
- 2023-03-31 filing 8-K items 8.01,9.01
- 2023-03-31 filing POS EX
- 2023-03-31 filing 424B3
- 2023-03-30 filing Annual report (10-K)
- 2023-03-30 filing 8-K items 2.02,9.01
- 2023-02-10 filing EFFECT
- 2023-02-10 filing 424B3
- 2023-02-08 filing CORRESP
- 2023-02-07 filing S-1/A
- 2023-02-06 filing CORRESP
- 2023-01-19 filing UPLOAD
- 2023-01-09 filing 8-K items 2.02,7.01,9.01
- 2023-01-05 filing CORRESP
- 2023-01-05 filing S-1/A
- 2023-01-03 filing S-8
- 2022-12-19 filing UPLOAD
- 2022-12-13 filing SC 13D/A
- 2022-11-30 filing Registration (S-1)
- 2022-11-23 filing 3/A
- 2022-11-18 filing 8-K items 8.01
- 2022-11-15 filing 8-K items 2.02,9.01
- 2022-11-14 filing SC 13D
- 2022-11-14 filing 8-K/A items 2.01,9.01
- 2022-11-10 filing Quarterly report (10-Q)
- 2022-11-07 filing 8-K/A items 4.01,5.03,5.05,8.01,9.01
- 2022-11-07 officer change 8-K items 1.01,2.01,3.02,3.03,5.01,5.02,5.06,9.01
- 2022-11-01 filing 25-NSE
- 2022-11-01 name change Name changed from Avista Public Acquisition Corp. II
- 2022-10-24 officer change 8-K items 5.02,5.07,8.01,9.01
- 2022-10-03 filing 425
- 2022-10-03 filing 425
- 2022-09-30 filing EFFECT
- 2022-09-30 filing 424B3
- 2022-09-28 filing CORRESP
- 2022-09-27 filing S-4/A
- 2022-09-27 filing CORRESP
- 2022-09-21 filing UPLOAD
- 2022-09-16 filing SEC STAFF LETTER
- 2022-09-13 filing S-4/A
- 2022-09-12 filing CORRESP
- 2022-09-07 filing UPLOAD
- 2022-08-25 officer change 8-K items 3.01,5.02
- 2022-08-24 filing 425
- 2022-08-22 filing CORRESP
- 2022-08-22 filing S-4/A
- 2022-08-15 filing UPLOAD
- 2022-08-12 filing Quarterly report (10-Q)
- 2022-07-26 filing S-4/A
- 2022-07-26 filing CORRESP
- 2022-07-15 filing UPLOAD
- 2022-06-21 filing 425
- 2022-06-21 filing 8-K items 7.01,9.01
- 2022-06-13 filing S-4/A
- 2022-06-10 filing CORRESP
- 2022-05-31 filing SEC STAFF LETTER
- 2022-05-27 filing UPLOAD
- 2022-05-20 filing Quarterly report (10-Q)
- 2022-05-16 filing NT 10-Q
- 2022-05-05 filing 425
- 2022-04-29 filing DEL AM
- 2022-04-28 filing S-4
- 2022-03-28 filing Annual report (10-K)
- 2022-03-24 filing 425
- 2022-03-24 filing 8-K items 1.01,3.02,9.01
- 2022-03-23 filing 425
- 2022-03-23 filing 8-K items 8.01,9.01
- 2022-03-14 filing 8-K items 2.03,9.01
- 2022-01-28 filing 8-K/A items 8.01,9.01
- 2022-01-12 filing 10-Q/A
- 2021-12-01 filing 8-K items 4.02
- 2021-11-10 filing Quarterly report (10-Q)
- 2021-09-27 filing 8-K items 8.01,9.01
- 2021-09-23 filing Quarterly report (10-Q)
- 2021-08-18 filing 8-K items 8.01,9.01
- 2021-08-12 filing 8-K items 8.01,9.01
- 2021-08-11 filing 424B4
- 2021-08-10 filing CERT
- 2021-08-09 filing EFFECT
- 2021-08-09 filing 8-A12B
- 2021-08-05 filing CORRESP
- 2021-08-05 filing CORRESP
- 2021-07-28 filing CORRESP
- 2021-07-28 filing S-1/A
- 2021-07-06 filing UPLOAD
- 2021-06-17 filing Registration (S-1)
- 2021-05-12 filing DRSLTR
- 2021-05-12 filing DRS/A
- 2021-04-14 filing UPLOAD
- 2021-03-19 filing DRS
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-10-30 (within 30 days) 10-Q filed
- 2026-10-30 (within 30 days) 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-08-06 (older) 10-Q filed
- 2026-08-06 (older) 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-07-13 (older) 8-K filed: Item 5.02 officer or director change
- 2026-06-18 (older) 8-K filed: Item 5.07 shareholder vote
- 2026-05-07 (older) 10-Q filed
- 2026-05-07 (older) 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-21; the colour is also written out in words.
COUNTS FROM THIS PAGERelationships at a glance
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NASDAQ:OABI The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
2 possible matches held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 1846253 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | OABI / Nasdaq, Nasdaq | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| CUSIP | 68218J103 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001846253 | SEC EDGAR |
possible match: matched by name only, not merged (1)
Identifiers carried by records that share the company's exact name. Not merged into the identity above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| EPA FRS id | 110071517243 (OMNIAB, INC.) | name-exact:legal-name: same registered legal name as 'OmniAb, Inc.' | EPA ECHO facilities |
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Revenue (fiscal year ended 2025-12-31) | $18,666,000 | 2025-12-31 | 10-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax | as filed | 2026-11-21 00:38 UTC | Report an error |
| Net income (loss) (fiscal year ended 2025-12-31) | -$64,779,000 | 2025-12-31 | 10-K, XBRL NetIncomeLoss | as filed | 2026-11-21 00:38 UTC | Report an error |
| Total assets (at 2025-12-31) | $300,914,000 | 2025-12-31 | 10-K, XBRL Assets | as filed | 2026-11-21 00:38 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | $267,027,000 | 2025-12-31 | 10-K, XBRL StockholdersEquity | as filed | 2026-11-21 00:38 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $25,524,000 | 2025-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | as filed | 2026-11-21 00:38 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-02 | SEC EDGAR company profile | as filed | 2026-11-21 00:38 UTC | Report an error |
| SIC industry | 8731 Services-Commercial Physical & Biological Research | 2026-11-02 | SEC EDGAR company profile | as filed | 2026-11-21 00:38 UTC | Report an error |
| State of incorporation | DE | 2026-11-02 | SEC EDGAR company profile | as filed | 2026-11-21 00:38 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-02 | SEC EDGAR company profile | as filed | 2026-11-21 00:38 UTC | Report an error |
| Business address | 5980 HORTON STREET, SUITE 600, EMERYVILLE, CA, 94608 | 2026-11-02 | SEC EDGAR company profile | as filed | 2026-11-21 00:38 UTC | Report an error |
| Exchanges | Nasdaq, Nasdaq | 2026-11-02 | SEC EDGAR company profile | as filed | 2026-11-21 00:38 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Operating cash flow (fiscal year ended 2025-12-31) | -$36,455,000 | 2025-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | as filed | 2026-11-21 00:38 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31) | $565,000 | 2025-12-31 | 10-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment | as filed | 2026-11-21 00:38 UTC | Report an error |
| Operating lease liabilities (at 2025-12-31) | $20,334,000 | 2025-12-31 | 10-K, XBRL OperatingLeaseLiability | as filed | 2026-11-21 00:38 UTC | Report an error |
| Form D total offering amount (D filed 2025-09-10) | $29,998,991 | 2025-09-10 | D | as filed | 2026-11-21 00:38 UTC | Report an error |
| Form D total amount sold (D filed 2025-09-10) | $29,998,991 | 2025-09-10 | D | as filed | 2026-11-21 00:38 UTC | Report an error |
| Form D industry group | Biotechnology | 2025-09-10 | D | as filed | 2026-11-21 00:38 UTC | Report an error |
| Form D revenue range | Decline to Disclose | 2025-09-10 | D | as filed | 2026-11-21 00:38 UTC | Report an error |
| Form D date of first sale | 2025-08-26 | 2025-09-10 | D | as filed | 2026-11-21 00:38 UTC | Report an error |
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-10-30 · accession 0001846253-26-000051
| Item | Value | Period | Form | Filed | Accession | Retrieved | Report |
|---|---|---|---|---|---|---|---|
| Revenue | $3,993,000 | 3 months ended 2026-09-30 | 10-Q | 2026-10-30 | 0001846253-26-000051 | 2026-11-21 00:38 UTC | Report an error |
| Net income (loss) | -$15,728,000 | 3 months ended 2026-09-30 | 10-Q | 2026-10-30 | 0001846253-26-000051 | 2026-11-21 00:38 UTC | Report an error |
| Cash and cash equivalents | $22,883,000 | at 2026-09-30 | 10-Q | 2026-10-30 | 0001846253-26-000051 | 2026-11-21 00:38 UTC | Report an error |
| Contract liabilities, current | $5,238,000 | at 2026-09-30 | 10-Q | 2026-10-30 | 0001846253-26-000051 | 2026-11-21 00:38 UTC | Report an error |
| Contract liabilities, noncurrent | $9,735,000 | at 2026-09-30 | 10-Q | 2026-10-30 | 0001846253-26-000051 | 2026-11-21 00:38 UTC | Report an error |
Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-10-30 Filing 10-Q filed
- 2026-10-30 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-08-06 Filing 10-Q filed
- 2026-08-06 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-07-13 Filing 8-K filed: Item 5.02 officer or director change
- 2026-06-18 Filing 8-K filed: Item 5.07 shareholder vote
- 2026-05-07 Filing 10-Q filed
- 2026-05-07 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-04-29 Filing ARS filed
- 2026-04-29 Filing DEFA14A filed
- 2026-04-29 Filing DEF 14A filed
- 2026-03-04 Filing 10-K filed
- 2026-03-04 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-01-30 Filing 8-K filed: Item 5.03 charter or bylaw amendment; Item 9.01 exhibits
- 2025-11-04 Filing 10-Q filed
- 2025-11-04 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2025-09-19 Filing EFFECT filed
- 2025-09-17 Filing CORRESP filed
- 2025-09-16 Filing UPLOAD filed
- 2025-09-12 Filing S-3 filed
- 2025-09-10 Filing D filed
- 2025-08-25 Filing 8-K filed: Item 1.01 material agreement; Item 3.02 unregistered equity sale; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2025-08-06 Filing 10-Q filed
- 2025-08-06 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2025-06-18 Filing 8-K filed: Item 5.07 shareholder vote
8-K item text, as filed (excerpts)
- 2026-10-30 8-K Item 2.02, Results of Operations and Financial Condition
On October 30, 2026, OmniAb, Inc. issued a press release announcing its financial results for the three and nine months ended September 30, 2026. A copy of this press release is furnished herewith as Exhibit 99.1 to this report. In accordance with General Instruction B.2. of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set… the 8-K · retrieved 2026-11-21 00:38 UTC - 2026-08-06 8-K Item 2.02, Results of Operations and Financial Condition
On August 6, 2026, OmniAb, Inc. issued a press release announcing its financial results for the three and six months ended June 30, 2026. A copy of this press release is furnished herewith as Exhibit 99.1 to this report. In accordance with General Instruction B.2. of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by… the 8-K · retrieved 2026-11-21 00:38 UTC
Each excerpt is the first part of the item's own text, copied as filed and cut at a word; the filing has the rest.
POSSIBLE MATCHES · GROUPED BY SOURCE8. Enforcement by agency
EPA ECHO facilities (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchOMNIAB, INC. · exact legal name · sx:epa:110071517243 Compare
EPA RCRA hazardous waste (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchOMNIAB, INC. · exact legal name · sx:rcra:CAR000359638 Compare
Each record's own page holds its date and the agency document. Matched by exact name only; none of these is counted in the headline.
AS FILED · LARGEST HOLDERS10. 13F institutional holders
| Rank | Holder (13F filer) | Value held | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|---|
| 1 | Whitefort Capital Management, LP | $25,211,699 | 2026-06-30 | SEC 13F filing | 2026-11-21 00:38 UTC | Report an error |
| 2 | BlackRock, Inc. | $21,887,827 | 2026-06-30 | SEC 13F filing | 2026-11-21 00:38 UTC | Report an error |
| 3 | NOMURA HOLDINGS INC | $12,369,274 | 2026-06-30 | SEC 13F filing | 2026-11-21 00:38 UTC | Report an error |
| 4 | CADIAN CAPITAL MANAGEMENT, LP | $10,361,080 | 2026-06-30 | SEC 13F filing | 2026-11-21 00:38 UTC | Report an error |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | $9,476,796 | 2026-06-30 | SEC 13F filing | 2026-11-21 00:38 UTC | Report an error |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | $7,096,381 | 2026-06-30 | SEC 13F filing | 2026-11-21 00:38 UTC | Report an error |
| 7 | RICE HALL JAMES & ASSOCIATES, LLC | $6,421,668 | 2026-06-30 | SEC 13F filing | 2026-11-21 00:38 UTC | Report an error |
| 8 | PRIVATE MANAGEMENT GROUP INC | $5,768,134 | 2026-06-30 | SEC 13F filing | 2026-11-21 00:38 UTC | Report an error |
| 9 | STATE STREET CORP | $5,248,531 | 2026-06-30 | SEC 13F filing | 2026-11-21 00:38 UTC | Report an error |
| 10 | DIMENSIONAL FUND ADVISORS LP | $3,105,584 | 2026-06-30 | SEC 13F filing | 2026-11-21 00:38 UTC | Report an error |
13F as filed: the holder's own report of its position value at the quarter end.
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/1846253.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001846253. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.